CRISPR基因組療法市場：按產品類型、應用、最終用戶和地區分類

據估計，CRISPR基因治療市場在2026年將達到55.8億美元，預計2033年將達到208.1億美元。預計從2026年到2033年，其複合年成長率將達到20.7%。

全球CRISPR基因組學市場涵蓋試劑盒和試劑、文庫和載體設計等產品類型，並應用於腫瘤學、遺傳疾病和基因組工程等領域。這些產品被生物製藥公司、合約研究組織（CRO）和基因研究實驗室等眾多行業廣泛採用，從而提高了效率、性能和可靠性。這些領域應用範圍的不斷擴大，以及持續的產品創新，將繼續推動市場成長。

市場動態：

關鍵應用領域需求的成長、對效率和性能日益重視以及持續的產品創新，預計將是推動全球 CRISPR 基因組療法市場成長的主要因素。生物製藥公司和合約研究組織 (CRO) 的廣泛應用，以及對先進解決方案投資的增加，也進一步促進了市場擴張。

例如，供應商正日益開發針對腫瘤學及相關應用領域的客製化解決方案。此外，持續的研發投入和新技術的整合預計將在預測期內為市場參與者創造新的成長機會。

本研究的主要特點：

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據公司概況、產品系列、主要亮點、財務績效和策略等參數，介紹了全球 CRISPR 基因組治療市場主要參與者的概況。
• 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份「全球 CRISPR 基因組療法市場」報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過分析全球 CRISPR 基因組治療市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特五力分析
• 併購情景

第4章：全球CRISPR基因組療法市場

• 供給面和需求面分析
• 經濟影響

第5章 全球CRISPR基因組療法市場：依產品類型分類，2021-2033年

• 試劑盒和試劑
• 圖書館
• 向量設計
• 檢測設計
• 其他

第6章 全球CRISPR基因組療法市場：依應用領域分類，2021-2033年

• 腫瘤學
• 遺傳性疾病
• 基因組工程
• 其他

第7章 全球CRISPR基因組療法市場：依最終使用者分類，2021-2033年

• 生物製藥公司
• 受託研究機構（CRO）
• 基因研究實驗室
• 其他

第8章 全球CRISPR基因組療法市場：按地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 印度
  • 中國
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 亞太地區的其他國家
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第9章 競爭情勢

• Merck KgaA
• Thermo Fisher Scientific Inc.
• Origene Technologies, Inc.
• New England Biolabs
• Intellia Therapeutics, Inc.
• GenScript
• GeneCopoeia, Inc.
• Cellectis
• Mammoth Biosciences
• Precision Biosciences, Inc.
• Synthego Corporation
• CRISPR Therapeutics
• Horizon Discovery Group plc
• Lonza Group Ltd.
• Takara Bio Inc.

第10章

• 調查方法
• 關於本公司

CRISPR Genomic Cure Market is estimated to be valued at USD 5.58 Bn in 2026 and is expected to reach USD 20.81 Bn by 2033, growing at a compound annual growth rate (CAGR) of 20.7% from 2026 to 2033.

The global crispr genomic cure market comprises product type categories such as Kits & Reagents, Libraries, and Vector Design, serving applications including Oncology, Genetic Diseases, and Genomic Engineering. These offerings are adopted across Biopharmaceutical Companies, Contract Research Organizations (CROs), and Genetic Research Laboratories and other areas, where they support improved efficiency, performance, and reliability. Growing adoption across these segments, combined with ongoing product innovation, continues to support expansion of the market.

Market Dynamics:

Rising demand across key application areas, increasing emphasis on efficiency and performance, and continued product innovation are major factors expected to drive growth of the global crispr genomic cure market. Expanding adoption among Biopharmaceutical Companies, and Contract Research Organizations (CROs) and growing investment in advanced solutions are further supporting market expansion.

For instance, providers are increasingly developing offerings tailored to Oncology and related applications. Moreover, ongoing research and development, along with the integration of new technologies, is expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global crispr genomic cure market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., Origene Technologies, Inc., New England Biolabs, Intellia Therapeutics, Inc., GenScript, GeneCopoeia, Inc., Cellectis, Mammoth Biosciences, Precision Biosciences, Inc., Synthego Corporation, CRISPR Therapeutics, Horizon Discovery Group plc, Lonza Group Ltd., and Takara Bio Inc, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global crispr genomic cure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global crispr genomic cure market.

Detailed Segmentation:

• Global CRISPR Genomic Cure Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
• Kits & Reagents
• Libraries
• Vector Design
• Assay Design
• Others
• Global CRISPR Genomic Cure Market, By Application (Revenue, USD Bn, 2021 - 2033)
• Oncology
• Genetic Diseases
• Genomic Engineering
• Others
• Global CRISPR Genomic Cure Market, By End User (Revenue, USD Bn, 2021 - 2033)
• Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Genetic Research Laboratories
• Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles:
• Merck KGaA*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
• Thermo Fisher Scientific Inc.
• Origene Technologies, Inc.
• New England Biolabs
• Intellia Therapeutics, Inc.
• GenScript
• GeneCopoeia, Inc.
• Cellectis
• Mammoth Biosciences
• Precision Biosciences, Inc.
• Synthego Corporation
• CRISPR Therapeutics
• Horizon Discovery Group plc
• Lonza Group Ltd.
• Takara Bio Inc

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • CRISPR Genomic Cure Market, By Product Type
  • CRISPR Genomic Cure Market, By Application
  • CRISPR Genomic Cure Market, By End User
  • CRISPR Genomic Cure Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER€(TM)s Analysis
• Merger and Acquisition Scenario

4. Global CRISPR Genomic Cure Market

• Supply Side and Demand Side Analysis
• Economic Impact

5. Global CRISPR Genomic Cure Market, By Product Type, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Kits & Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Libraries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Vector Design
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Assay Design
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global CRISPR Genomic Cure Market, By Application, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Genetic Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Genomic Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global CRISPR Genomic Cure Market, By End User, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Genetic Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global CRISPR Genomic Cure Market, By Region, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • India
    • China
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of the APAC
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Merck KgaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Origene Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• New England Biolabs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Intellia Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GenScript
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GeneCopoeia, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cellectis
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mammoth Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Precision Biosciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Synthego Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CRISPR Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Horizon Discovery Group plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lonza Group Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takara Bio Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us